The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 Oct 2007 07:00

Embargoed Release: 07:00hrs, Thursday 25 October 2007

SOPHEON PLC ("Sopheon") TRADING UPDATE Sopheon, the international provider of software and services that improve thefinancial return from innovation and product development investments issues atrading update.Since the mid year, we have divided our effort between our core pipeline, theadditional pipeline resulting from our acquisition of Alignent Software and thecustomer conversion opportunities stemming from our recently announcedagreement with IDe. During that period we added three new customers for ourAccolade solution and three for Vision Strategist, the product acquired withAlignent. We also closed six extension orders within the combined customerbase. This activity brings the total number of customers licensing Sopheonsoftware to 131, up from 87 upon entering 2007. The total of 131 is representedby 99 for the Sopheon platform and 35 for the Alignent platform, of which 3 arealso Accolade users.The Alignent and IDe transactions, although somewhat disruptive over the summermonths, have substantially strengthened Sopheon's market position and businessprospects. Most of the core integration activities associated with ouracquisition of Alignent are now behind us. People, facilities, and resourceswere successfully integrated in the third quarter. In addition to the new salesnoted above, we expect to renew all but one of Alignent's recurring maintenanceand license contracts that were due for renewal between the acquisition dateand year-end, underlining the strong business value of the Vision Strategistproduct.In parallel with commercial activities, we have continued to invest heavily inproduct development. In September, our development team released a new versionof Vision Strategist to the market. In the third quarter we announced that anintegration of the portfolio management capabilities of our Accolade solutionwith Vision Strategist, and made the integrated solution available forpurchase. Initial orders are expected in the fourth quarter. Looking forward,we are on track to introduce the most significant new release of our Accoladesolution in our history. Scheduled for introduction at the end of the year,this release will extend the value and functionality of Sopheon's software forthe non-process manufacturing markets, including the large aerospace, defenceand automobile sectors. As part of this release we will also be introducing anew version of Vision Strategist. The combination will be the first in theindustry to integrate product planning and product development execution, andis expected to have immediate impact on our business development efforts.In August we announced that we had entered into an exclusive agreement to offertransitional services to the customers of IDe, a former Sopheon competitor. Wehave since contacted all of IDe's customers, and three have already signedagreements to adopt Accolade. This will drive maintenance and services revenuein the short term, and possible license extension orders in the medium term.The initial services engagements were kicked off in early October. Twoadditional customers have signed letters-of-intent, indicating a desire to workwith Sopheon moving forward. We remain in discussion with a handful of others.Contracted and recurring revenue visibility for 2007 stands at ‚£5.8m. We haveoften noted the influence that the timing of individual sales can have on ourresults, and achieving our objectives for the year will remain challenging;however, in our interim statement we also noted that our sales funnel wasrobust, with a number of potentially large deals in the prospect population,and this remains the case. Subject to the above, the current high levels ofactivity in our pipeline, coupled with existing visibility, give us continuedconfidence that our full-year performance for 2007 will show substantialimprovement over 2006. -Ends-

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Andrew Tan Hansard Communications Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 David Newton Seymour Pierce Tel : + 44 (0) 207 107 8000About SopheonSopheon is an international provider of software and services thathelp organizations improve the business impact of product innovation. Sopheon'ssolutions automate and govern the innovation process, enabling companies toincrease revenue and profits from new products. Sopheon is listed on the AIMMarket of the London Stock Exchange and on the Euronext in the Netherlands. Formore information, please visit www.sopheon.com.

SOPHEON PLC
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.